NCT07305168 A Multicenter Retrospective Analysis of Postoperative Respiratory Complications in Children With Obstructive Sleepapnea
| NCT ID | NCT07305168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Antwerp |
| Condition | Obstructive Sleep Apnea |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-05-02 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-05-02 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This retrospective observational study aims to evaluate postoperative respiratory complications (PORC) after (adeno)tonsillectomy in children with OSA. In order to increase the number of patients available for analysis, we will merge data collected at UZA with data collected at the the Department of Sleep Laboratory and Sleep Surgery at the Heim Pal National Pediatric Institute, Hungary. These colleagues performed an identical prospective data collection.
Eligibility Criteria
Inclusion Criteria: * scheduled for (adeno)tonsillectomy as treatment for OSAS Exclusion Criteria: * other surgery than (adeno)tonsillectomy performed as treatment for OSAS * Polysomnography not available within 1 year before surgery
Contact & Investigator
Vera Saldien, MD
PRINCIPAL INVESTIGATOR
University Hospital, Antwerp
Frequently Asked Questions
Who can join the NCT07305168 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 18 Years, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07305168 currently recruiting?
Yes, NCT07305168 is actively recruiting participants. Contact the research team at vera.saldien@uza.be for enrollment information.
Where is the NCT07305168 trial being conducted?
This trial is being conducted at Edegem, Belgium, Budapest, Hungary.
Who is sponsoring the NCT07305168 clinical trial?
NCT07305168 is sponsored by University Hospital, Antwerp. The principal investigator is Vera Saldien, MD at University Hospital, Antwerp. The trial plans to enroll 200 participants.